Alnylam Pharmaceuticals, Inc. (ALNY)

339.41 +6.41 (+1.92%) USD  |  NASDAQ  |  Apr 14, 16:00
341.99 +2.58 (+0.76%) After-Hours: 20:00
More

Alnylam Pharmaceuticals Quarterly Actual Revenue

Quarterly Actual Revenue Chart

View Quarterly Actual Revenue for ALNY.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Quarterly Actual Revenue Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Quarterly Actual Revenue Range, Past 5 Years

View Quarterly Actual Revenue Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Quarterly Actual Revenue Benchmarks

View Quarterly Actual Revenue Benchmarks
Start Trial
Pfizer Inc. Upgrade
Eli Lilly & Co. Upgrade
Ionis Pharmaceuticals, Inc. Upgrade
Regeneron Pharmaceuticals, Inc. Upgrade
Sarepta Therapeutics, Inc. Upgrade